Abstract
Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key characteristics of cancer development. Nonetheless, some tumors show hardly any CNAs, a remarkable phenomenon in oncogenesis. Head and neck squamous cell carcinomas (HNSCCs) arise by either exposure to carcinogens, or infection with the human papillomavirus (HPV). HPV-negative HNSCCs are generally characterized by many CNAs and frequent mutations in CDKN2A, TP53, FAT1, and NOTCH1. Here, we present the hallmarks of the distinct subgroup of HPV-negative HNSCC with no or few CNAs (CNA-quiet) by genetic profiling of 802 oral cavity squamous cell carcinomas (OCSCCs). In total, 73 OCSCC (9.1%) are classified as CNA-quiet and 729 as CNA-other. The CNA-quiet group is characterized by wild-type TP53, frequent CASP8 and HRAS mutations, and a less immunosuppressed tumor immune microenvironment with lower density of regulatory T cells. Patients with CNA-quiet OCSCC are older, more often women, less frequently current smokers, and have a better 5-year overall survival compared to CNA-other OCSCC. This study demonstrates that CNA-quiet OCSCC should be considered as a distinct, clinically relevant subclass. Given the clinical characteristics, the patient group with these tumors will rapidly increase in the aging population.
| Original language | English |
|---|---|
| Article number | 9060 |
| Pages (from-to) | 1-18 |
| Number of pages | 18 |
| Journal | Nature Communications |
| Volume | 15 |
| Early online date | 20 Oct 2024 |
| DOIs | |
| Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© 2024. The Author(s).
Funding
The authors wish to thank all patients who participated in this study, Steven M. Mes PhD for help with and design of the MLPA assay, Widad Rifi MSc for contribution with probe design and optimization and technical assistance, Dennis N.L.M. Nijenhuis MSc for help with the multiplex immunohistochemistry, Leon Wils MSc for help with the cancer genome atlas mutational analysis, Marijke Stigter-van Walsum for help with targeted sequencing, Microscopy and Cytometry Core Facility, Amsterdam UMC for facilitating the Vectra Polaris (Akoya), clinicians and nurses from the department of Otolaryngology-head and neck surgery from Amsterdam UMC for support with tissue collection, Cancer Center Amsterdam (CCA) for financially support of this work (PV 19/02).
| Funders | Funder number |
|---|---|
| Amsterdam University Medical Centers | PV 19/02 |
| Amsterdam University Medical Centers |
Fingerprint
Dive into the research topics of 'Hallmarks of a genomically distinct subclass of head and neck cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver